Literature DB >> 3083914

Cholestatic jaundice caused by ethambutol.

M Gulliford, A D Mackay, K Prowse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3083914      PMCID： PMC1339973          DOI： 10.1136/bmj.292.6524.866

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.

Authors:  A W Lees; G W Allan; J Smith; W F Tyrell; R J Fallon
Journal:  Chest       Date:  1972-06       Impact factor: 9.410

2.  The problems of tuberculosis in the elderly.

Authors:  A D Mackay; R B Cole
Journal:  Q J Med       Date:  1984
  2 in total
  4 in total

1.  Liver and pancreatic injury induced by antituberculous therapy.

Authors:  M Markov; K Patel; A Raeesy; A Bant; D H Van Thiel; A Nadir
Journal:  Dig Dis Sci       Date:  2007-02-15       Impact factor: 3.199

Review 2.  Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status.

Authors:  F Durand; G Jebrak; D Pessayre; M Fournier; J Bernuau
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

Review 3.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

Review 4.  Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature.

Authors:  David A Barr; Pravistadevi K Ramdial
Journal:  BMC Infect Dis       Date:  2012-10-14       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.